Applied InSilico Announces Its First Top Five Pharmaceutical Customer; GlaxoSmithKline Licenses ELE(TM) Evolutionary Learning Environment

CHIPPENHAM, United Kingdom--(BUSINESS WIRE)--Nov. 2, 2005--Applied InSilico, a provider of analytical solutions for drug discovery and development, today announced that GlaxoSmithKline (GSK) has signed a multi-year agreement for its ELE(tm) (Evolutionary Learning Environment) software platform. Financial details were not disclosed.

Back to news